nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—Paget's disease of bone—osteoarthritis	0.472	0.522	CtDrD
Alendronate—osteoporosis—osteoarthritis	0.431	0.478	CtDrD
Alendronate—PTPRS—ECM proteoglycans—MATN1—osteoarthritis	0.01	0.105	CbGpPWpGaD
Alendronate—PTPRS—ECM proteoglycans—MATN3—osteoarthritis	0.01	0.105	CbGpPWpGaD
Alendronate—PTPRS—ECM proteoglycans—ASPN—osteoarthritis	0.01	0.105	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—TNFSF11—osteoarthritis	0.00598	0.0626	CbGpPWpGaD
Alendronate—PTPRS—ECM proteoglycans—COMP—osteoarthritis	0.00577	0.0603	CbGpPWpGaD
Alendronate—PTPRS—ECM proteoglycans—FMOD—osteoarthritis	0.0055	0.0575	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—TIMP1—osteoarthritis	0.00422	0.0441	CbGpPWpGaD
Alendronate—PTPRS—ECM proteoglycans—COL9A2—osteoarthritis	0.0036	0.0376	CbGpPWpGaD
Alendronate—PTPRS—ECM proteoglycans—COL9A1—osteoarthritis	0.0035	0.0365	CbGpPWpGaD
Alendronate—PTPRS—ECM proteoglycans—BGN—osteoarthritis	0.00306	0.032	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—ASPN—osteoarthritis	0.00286	0.0299	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—MATN1—osteoarthritis	0.00286	0.0299	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—MATN3—osteoarthritis	0.00286	0.0299	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—CRP—osteoarthritis	0.00259	0.0271	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—COMP—osteoarthritis	0.00164	0.0172	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—GDF5—osteoarthritis	0.00164	0.0172	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—FMOD—osteoarthritis	0.00157	0.0164	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—COL10A1—osteoarthritis	0.0014	0.0146	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—ADAMTS5—osteoarthritis	0.00131	0.0137	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—ADAMTS3—osteoarthritis	0.00131	0.0137	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—ADAMTS4—osteoarthritis	0.00112	0.0117	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—COL9A2—osteoarthritis	0.00103	0.0107	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—COL9A1—osteoarthritis	0.000996	0.0104	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—IL6—osteoarthritis	0.000947	0.0099	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—BGN—osteoarthritis	0.000873	0.00913	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—COL2A1—osteoarthritis	0.000832	0.0087	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—CTSK—osteoarthritis	0.000803	0.0084	CbGpPWpGaD
Alendronate—Risedronate—PTGS2—osteoarthritis	0.000726	0.529	CrCbGaD
Alendronate—PTPRS—Extracellular matrix organization—MMP13—osteoarthritis	0.000707	0.00739	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—BMP2—osteoarthritis	0.000683	0.00714	CbGpPWpGaD
Alendronate—Clodronate—PTGS2—osteoarthritis	0.000647	0.471	CrCbGaD
Alendronate—PTPRS—ECM proteoglycans—TGFB1—osteoarthritis	0.000636	0.00665	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—TIMP1—osteoarthritis	0.000609	0.00636	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—MMP3—osteoarthritis	0.000473	0.00495	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—MMP1—osteoarthritis	0.000378	0.00396	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—FN1—osteoarthritis	0.000345	0.00361	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—MMP2—osteoarthritis	0.000293	0.00306	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00027	0.00282	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—FMOD—osteoarthritis	0.00022	0.0023	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—MMP9—osteoarthritis	0.00022	0.0023	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IHH—osteoarthritis	0.000196	0.00205	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—TGFB1—osteoarthritis	0.000181	0.0019	CbGpPWpGaD
Alendronate—FDPS—Metabolism—FMOD—osteoarthritis	0.000148	0.00154	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TGFBI—osteoarthritis	0.000146	0.00153	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MCF2L—osteoarthritis	0.000138	0.00144	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IHH—osteoarthritis	0.000138	0.00144	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IL6—osteoarthritis	0.000129	0.00135	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—GSTO1—osteoarthritis	0.000127	0.00132	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—BGN—osteoarthritis	0.000123	0.00128	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PTGES—osteoarthritis	0.00012	0.00126	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—COL9A2—osteoarthritis	0.000101	0.00106	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—COL9A1—osteoarthritis	9.8e-05	0.00103	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTO1—osteoarthritis	8.48e-05	0.000886	CbGpPWpGaD
Alendronate—FDPS—Metabolism—BGN—osteoarthritis	8.21e-05	0.000858	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—BMP2—osteoarthritis	6.72e-05	0.000703	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SMAD3—osteoarthritis	6.02e-05	0.000629	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	5.3e-05	0.000554	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MMP3—osteoarthritis	4.66e-05	0.000487	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SMAD3—osteoarthritis	4.22e-05	0.000441	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LEP—osteoarthritis	3.6e-05	0.000377	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PTGS2—osteoarthritis	3.53e-05	0.000369	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ESR1—osteoarthritis	3.44e-05	0.00036	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FN1—osteoarthritis	3.4e-05	0.000355	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IGF1—osteoarthritis	2.98e-05	0.000311	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TGFB1—osteoarthritis	2.55e-05	0.000266	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CXCL8—osteoarthritis	2.39e-05	0.00025	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PTGS2—osteoarthritis	2.36e-05	0.000247	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MMP9—osteoarthritis	2.17e-05	0.000226	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IL6—osteoarthritis	1.92e-05	0.000201	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TGFB1—osteoarthritis	1.78e-05	0.000187	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL6—osteoarthritis	1.34e-05	0.000141	CbGpPWpGaD
